Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Shoblock

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
CNS Drug Reviews|April 28, 2007
The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activityJames R Shoblock
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 16, 2005
Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent miceJames R Shoblock, Nigel T Maidment
Psychopharmacology|October 2, 2009
The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortexNatalie Welty, James R Shoblock
Neurochemical Research|June 19, 2004
Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortexJames R Shoblock, Isabelle M Maisonneuve, Stanley D Glick
Neuropharmacology|May 28, 2005
The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preferenceJames R Shoblock, Jürgen Wichmann, Nigel T Maidment
Psychopharmacology|May 30, 2003
Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinctionJames R Shoblock, Isabelle M Maisonneuve, Stanley D Glick
Psychopharmacology|December 20, 2002
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in ratsJames R Shoblock, Eric B Sullivan, Isabelle M Maisonneuve, et al.
Frontiers in Pharmacology|April 6, 2019
<i>In vivo</i> Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 AgonistJames R Shoblock, Natalie Welty, Ian Fraser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 12, 2014
PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigsMichael Winterdahl, Hélène Audrain, Anne M Landau, et al.
Psychopharmacology|December 25, 2010
Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatementJames R Shoblock, Natalie Welty, Leah Aluisio, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
CNS Drug Reviews|April 28, 2007
The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activityJames R Shoblock
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 16, 2005
Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent miceJames R Shoblock, Nigel T Maidment
Psychopharmacology|October 2, 2009
The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortexNatalie Welty, James R Shoblock
Neurochemical Research|June 19, 2004
Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortexJames R Shoblock, Isabelle M Maisonneuve, Stanley D Glick
Neuropharmacology|May 28, 2005
The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preferenceJames R Shoblock, Jürgen Wichmann, Nigel T Maidment
Psychopharmacology|May 30, 2003
Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinctionJames R Shoblock, Isabelle M Maisonneuve, Stanley D Glick
Psychopharmacology|December 20, 2002
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in ratsJames R Shoblock, Eric B Sullivan, Isabelle M Maisonneuve, et al.
Frontiers in Pharmacology|April 6, 2019
<i>In vivo</i> Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 AgonistJames R Shoblock, Natalie Welty, Ian Fraser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 12, 2014
PET brain imaging of neuropeptide Y2 receptors using N-11C-methyl-JNJ-31020028 in pigsMichael Winterdahl, Hélène Audrain, Anne M Landau, et al.
Psychopharmacology|December 25, 2010
Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatementJames R Shoblock, Natalie Welty, Leah Aluisio, et al.
Pageof 2